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Termination of translation in eukaryotes is triggered by two polypeptide
chain release factors, eukaryotic class 1 polypeptide chain release factor
(eRF1) and eukaryotic class 2 polypeptide chain release factor 3. eRF1 is a
three-domain protein that interacts with eukaryotic class 2 polypeptide
chain release factor 3 via its C-terminal domain (C-domain). The high-reso-
lution NMR structure of the human C-domain (residues 277–437) has been
determined in solution. The overall fold and the structure of the b-strand
core of the protein in solution are similar to those found in the crystal
structure. The structure of the minidomain (residues 329–372), which was
ill-deﬁned in the crystal structure, has been determined in solution. The
protein backbone dynamics, studied using
15N-relaxation experiments,
showed that the C-terminal tail 414–437 and the minidomain are the most
ﬂexible parts of the human C-domain. The minidomain exists in solution
in two conformational states, slowly interconverting on the NMR time-
scale. Superposition of this NMR solution structure of the human
C-domain onto the available crystal structure of full-length human eRF1
shows that the minidomain is close to the stop codon-recognizing N-termi-
nal domain. Mutations in the tip of the minidomain were found to affect
the stop codon speciﬁcity of the factor. The results provide new insights
into the possible role of the C-domain in the process of translation termi-
nation.
Abbreviations
C-domain, C-terminal domain (or domain 3) of class 1 polypeptide chain release factor; DHPC, 1,2-dihexanoyl-sn-glycero-3-phosphocholine;
DMPC, 1,2-dimyristoyl-sn-glycero-3-phosphocholine; eRF1, eukaryotic class 1 polypeptide chain release factor; eRF3, eukaryotic class 2
polypeptide chain release factor 3; HSQC, heteronuclear single quantum coherence; M-domain, eukaryotic class 1 polypeptide chain release
factor middle domain (or domain 2); minidomain, residues 329–372 of human eRF1; N-domain, eukaryotic class 1 polypeptide chain release
factor N-terminal domain (or domain 1); NMD, nonsense-mediated decay; PP2A, protein phosphatase 2A; RDC, residual dipolar coupling;
Rex, conformational exchange contribution to R2; RF, release factor; R1, longitudinal or spin–lattice relaxation rate; R2, transverse or spin–spin
relaxation rate; S
2, order parameter reﬂecting the amplitude of picosecond–nanosecond bond vector dynamics; se, effective internal
correlation time; sm, overall rotational correlation time.
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Termination of translation in eukaryotes is governed
by the cooperative action of two interacting polypep-
tide chain factors, eukaryotic class 1 polypeptide chain
release factor (eRF1) and eukaryotic class 2 polypep-
tide chain release factor 3 (eRF3). The major functions
of eRF1 include recognition of each of the three stop
codons (UAA, UAG, or UGA) in the decoding center
of the small ribosomal subunit and the subsequent
peptidyl-tRNA hydrolysis. eRF3 is a ribosome-depen-
dent and eRF1-dependent GTPase encoded by an
essential gene that enhances the termination efﬁciency
by stimulating the activity of eRF1 [1–4].
eRF1 contains three structurally separated domains,
each of which can be assigned a speciﬁc function. The
N-terminal domain (N-domain) is involved in the rec-
ognition of the stop codon [1,5,6]. The middle domain
(M-domain) catalyzes the hydrolysis of the peptidyl-
tRNA ester bond within the peptidyltransferase center
of the 60S ribosome subunit [7,8]. The C-terminal
domain (C-domain) binds to eRF3 [9–12], and this
interaction increases the efﬁciency of translation termi-
nation [13,14]. However, in a simpliﬁed in vitro assay
for the measurement of release factor (RF) activity,
eRF1, deprived of the C-domain, still retains its RF
activity [15]. The combination of the human
M-domain and C-domain, in the absence of the
N-domain, is able to bind to the mammalian ribosome
and to induce the GTPase activity of eRF3 [16].
It has been found that eRF1 and eRF3 form ternary
and quaternary complexes in solution with GTP and
Mg
2+ (eRF1–eRF3–GTP and eRF1–eRF3–GTP–
Mg
2+) [17]. Yeast two-hybrid and deletion analyses
have revealed that residues 281–305 and 411–415 of
human eRF1 are important for its binding to eRF3,
but the last 22 residues (415–437) are not signiﬁcant
for this process [11]. In contrast, in the case of eRF1s
from the budding and ﬁssion yeast, the last 19 residues
of the C-terminal fragment are necessary for the
eRF1–eRF3 interaction [9,12]. As residues 300–303
and 411–412 correspond to the b-sheets in the central
hydrophobic core of the C-domain, it might be
expected that truncation of these residues would lead
to destabilization of the whole structure. This sugges-
tion is in full agreement with recent studies on the
yeast Y410S C-domain mutant [18].
The structure, dynamics and functions of the
C-domain have been studied much less intensively than
those of the M-domain or the N-domain. In the cur-
rently available crystal structure of human eRF1 [19],
coordinates exist only for the atoms that belong to the
main rigid core of the C-domain, and consequently the
C-domain structure has extensive unresolved fragments
in its mobile regions. More recently [20], the crystal
structure of human eRF1 in a complex with the trun-
cated form of eRF3 (residues 467–662) has been
solved. In particular, it has been found that the two
a-helices, a8 and a11, which belong to the main rigid
core of the C-domain, together with Arg192 and
Arg203 of the M-domain [21], form the interface with
eRF3. However, all of the mobile regions that could
not be seen in the crystal structure of human eRF1
[19] still remained undetermined in the structure of the
eRF1–eRF3 complex [20].
We report here the high-resolution NMR structure
of the human C-domain in solution, and present data
on its dynamics. On the basis of the structural data,
we have performed a mutational analysis of the
C-domain and investigated the impact of the mutants
on stop codon recognition.
Results
Resonance assignment
1H,
13C and
15N chemical shifts were made for 99%
of the protein backbone resonances of the isolated
C-domain. Only Asn277, Asn325, and Gln397, whose
amide group HN and
15N signals could not be reliably
determined because of signal overlap problems, were
not assigned. More than 78% of all of the observed
side chain
1H,
13C and
15N chemical shifts were also
determined.
The
1H,
15N-heteronuclear single quantum coherence
(HSQC) spectra, measured over the temperature range
288–313 K, showed only a minor effect of temperature
on the existence and line widths of the protein backbone
resonances. This suggests the absence of multiple con-
formations that interconvert on the millisecond time
scale. However, for several residues situated between
positions 329 and 372 (in particular, residues 333–344,
351, and 357–370) a duplicated set of signals of approxi-
mately equal intensity was observed (Fig. 1; Fig. S1).
This clearly indicates the presence of two conforma-
tional states of residues 329–372 (minidomain) of eRF1,
which is highly enriched in polar and charged residues.
Refolding of the C-domain leads to the presence of
only one conformational state. The refolding was
carried out by lowering the pH of the protein solution
from 7.0 to 3.5, and then restoring the pH to its initial
value. It is also worth noting that the relative popula-
tions of the two conformational states are affected by
the components of different diluted liquid crystalline
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[1,2-dihexanoyl-sn-glycero-3-phosphocholine (DHPC)⁄
1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC)]
[22], a set of signals is observed that belongs to one
conformation of the minidomain, whereas in the
poly(ethylene glycol)-based system [23], another set of
signals could be detected. Therefore, the sizes of the
relative populations and possibly the rate of conformer
interconversion are sensitive to the environment of the
domain.
For the great majority of the residues in the minido-
main, the differences between the chemical shifts of the
two conformational states are sufﬁciently large to
allow sequential assignments based on the use of
1H,
13C,
15N triple-resonance experiments (3D experi-
ment correlating the amide HN and the Ca signals, 3D
experiment correlating the amide HN and the Ca sig-
nal of the preceding amino acid, 3D experiment corre-
lating the amide NH with the Ca and Cb signals, 3D
experiment correlating the amide NH with the Ca and
Cb signals of the preceding amino acid, and 3D experi-
ment correlating the amide NH with the C¢ signal of
the preceding amino acid). Figure 2 presents the distri-
bution of the chemical shift differences between the
two protein conformers for the backbone amide pro-
ton, nitrogen and Ha signals for the minidomain.
These differences are concentrated in regions 333–344
and 357–370, presumably reﬂecting differences in the
structures in these regions. It should be noted that
there are no detectable differences in chemical shifts
for the remaining residues.
Structure determination
The existence of two distinct sets of resonances for the
minidomain allowed the determination of two families
representing the two conformational states of the solu-
tion structure of the C-domain (shown as a stereo view
in Fig. 3A). The structure determination was based on
more than 2140 experimental restraints, using data
obtained at 288 and 313 K (Table 1). This work made
use of the standard double-resonance
15N,
1H-NMR
and triple-resonance
15N,
13C,
1H-NMR experiments
applied to
13C-labeled and⁄or
13N-labeled samples of
the human C-domain. For most of the protein residues,
the number of NOE restraints per residue is between 15
and 25 (Fig. S2). However, the C-terminus and frag-
ment 336–338 have signiﬁcantly lower numbers of mea-
sured distance restraints. Therefore, extensive use of
residual dipolar couplings (RDCs), measured in several
alignment media, was important for the determination
of the structures of the conformers of the C-domain.
The dipolar couplings provided long-distance informa-
tion on the global folding of both conformers.
The structure of the protein core (residues 277–328
and 373–413) in both conformers (Fig. 3B,C) is in
good agreement with that of the corresponding part of
the crystal structure [19]. Four b-strands (b1, 301–303;
b2, 320–323; b6, 389–392; and b7, 409–412) form a
b-sheet with three antiparallel strands (1, 2 and 7) and
strand 6, which is parallel to strand 2. b-Strands are
located between the four a-helices (a1, 278–294; a2,
305–313; a4, 374–381; and a5, 397–405), with two of
Fig. 1.
1H,
15N-HSQC spectrum of the C-domain. Amide signals from residues that belong to the open protein conformation are marked with
asterisks.  marked peaks correspond to folded resonances, which would otherwise appear outside the spectral region shown.
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other side. The rmsd of the heavy atoms (Ca, C, and
N) of the protein core, when the NMR structures of
both conformers are superimposed on the crystal struc-
ture of human eRF1, is 1.58 ± 0.06 A ˚ .
The fold of the minidomain, for both protein con-
formations, contains identical secondary structural ele-
ments: b-strands (b3, 329–335; b4, 339–344; and b5,
367–372) and a distorted a-helix (a3, 348–356)
(Fig. 3B,C). The three b-strands of the minidomain are
all antiparallel, and form a single b-structure.
Two protein conformers
The main structural difference between the two pro-
tein conformers is in the orientation of a3 (resi-
dues 348–356), with respect to the b-structure of the
minidomain and the corresponding tilt of the loop
(residues 357–367) between a3 and b5 (Fig. 3B,C). In
one of the conformers (closed; Fig. 3C,E), the side
chain of His356 is on the top of the a-helix and in
closer contact with the negatively charged side chains
of Glu365 and Glu367, whereas in the second con-
former (open; Fig. 3B,D), His356 is closer to another
charged side chain, that of Asp353, and the aromatic
rings of Phe357 and Tyr331.
The two different orientations of the loops result
from the substantial change in the backbone conforma-
tion around Phe357, which results in the proximity of
Thr358 and Lys354 in the open conformer (Fig. 3B,D).
The average backbone torsion angles of Phe357 in the
ensemble of the open conformer are )6 0±3   (/) and
)3 8±4   (w); these values fall within the range
acceptable for an a-helical conformation. In the case of
the closed conformer (Fig. 3C,E), these values are
+57 ± 3  (/) and +6 ± 4  (w), which indicates the
site of a break in the a-helix (residues 348–356).
The difference between the conformers is clear from
the comparison of the intensities of the NOEs involv-
ing the HNs of Phe357 and Thr358 (Table S1). Such a
twist in the protein backbone conformation between
residues 354 and 358 causes a change in the proton–
proton distances and the intensities of the correspond-
ing NOEs (Fig. 4). Thus, the NOE between the HN of
Thr358 and the Ha of Ser355 could only be detected
for the open conformer, whereas a crosspeak between
the HN of Thr358 and the Ha of His356 could be seen
in both conformers (Fig. 4; Fig. S3). At the same time,
the intensity of the NOE between the HN of Phe357
and the Ha of Lys354 in the open conformer is larger
than in the closed conformer (Fig. S4). These observa-
tions are in full agreement with the structures of the
two protein conformations (Fig. 3D,E), calculated with
the extensive use of the RDCs for
1DNH, which greatly
helped with the accurate determination of the protein
backbone orientation.
The structure of the protein backbone in the central
part of loop 357–367 is similar for both conformers,
which is in accord with the nearly identical sets of
strong long-range, middle-range and intraresidue
NOEs found for the two conformers (Fig. S2). There
is also no signiﬁcant change in the conformation of
the polypeptide chain in region 365–372. The torsion
angle w of Gln364 differs by 180  in the two protein
conformers; however, this does not have a signiﬁcant
impact on the observed interatomic distances, partially
owing to the high mobility of this protein region.
Temperature effects
Raising the temperature from 298 to 313 K leads to a
signiﬁcant decrease in the intensities of all the NOEs
arising from the HN of Gly337 and all the sequential
and medium-range NOEs arising from the HN atoms
A
B
C
Fig. 2. Protein backbone chemical shift
differences between the resonances from
the two conformations of loop 357–367.
Absolute values of chemical shift differ-
ences are shown for: (A) Ha resonances;
(B) HN signals; and (C) amide
15N
resonances.
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However, there is no analogous temperature effect on
these signals in the closed conformer. This can be
explained by increased mobility of this region in the
open conformer, and partially by faster exchange of
the amide proton of Gly337 with water. The second
A
BC
D E
Fig. 3. The solution structure of the
C-domain. (A) Stereo view of the ensemble
of the ﬁnal 48 calculated structures.
Twenty-four structures of the closed protein
conformer are shown in red, and 24
structures of the open conformer are
shown in cyan. The N-termini and C-termini
are labeled. (B, C) The topology of the
secondary structure elements of the open
(B) and closed (C) protein conformers.
(D, E) The conformations of the minidomain
in the open (D) and closed (E) protein
conformers. The residues participating in
key interactions that could stabilize the two
conformers of the minidomain are
highlighted.
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speaks between the signal of the HN of Gly337 in the
open conformer and the signal of the water protons.
All of these observations indicate that the loop region
of the open conformer has a higher degree of mobility
than that in the closed protein conformer.
Testing the conformer stability
The HSQC spectra of samples of the human C-domain
from different preparations showed slightly different
relative populations of the two conformers. Therefore,
the effects of pH, ionic strength of the solution and
temperature on the populations of the two protein
conformers were examined (see Experimental proce-
dures). It was found that variation of pH in the range
between 6.3 and 7.7, of ionic strength between 25 and
100 mm NaCl and of temperature between 278 and
313 K did not lead to any detectable change in the
populations of the two conformers. However, as
described earlier, refolding of the protein from a solu-
tion at pH 3.5 resulted in only the closed conformer
being present in solution. Therefore, one hypothesis is
that the protonation state of the His356 side chain
could be crucial for protein folding and for the stabil-
ization of the conformers. At pH values above its pKa,
the imidazole ring of His is uncharged, and both con-
formers are stable. In attempts to experimentally detect
any possible pH dependence of the populations of the
two conformers, an NMR pH titration of the
C-domain in solution was carried out. However, a sig-
niﬁcant amount of aggregated protein was detected at
and below pH 6.0, which precluded the acquisition of
this experimental evidence. The fact that protein
expression gives equal populations of two protein con-
formations may also indicate that chaperones and⁄or
cell translation machinery could facilitate the folding
of the C-domain.
The relative populations of the two protein confor-
mations were found to be extremely sensitive to the
nature of the alignment media used in the RDC exper-
iments (see Experimental procedures). In n-alkyl-
poly(ethylene glycol)⁄n-alkyl alcohol medium [23], only
the closed conformer could be detected. However, in
media formed with phospholipid bicelles (DMPC⁄
DHPC and DMPC⁄DHPC⁄SDS), the open conformer
(90%) was mainly observed.
Backbone dynamics
Experimentally determined
15N-relaxation parameters
for the amide
15N nuclei (R1, longitudinal relaxation
rate; R2, transverse relaxation rate; and
15N{
1H}-NOE
values) measured at 298 K are shown in Fig. 5A–C.
Figure 5D also shows the calculated values of the
order parameter S
2, which reﬂects the amplitude of
picosecond–nanosecond amide bond vector dynamics,
and Fig. 5E shows additional line broadening (Rex)
resulting from protein motions on the millisecond time
scale. The best ﬁtting of the relaxation parameters
could only be obtained using a fully asymmetric tensor
model for the molecular rotational diffusion motions.
Analysis of the relaxation data (Fig. 5) shows that,
ignoring the trivial case of the C-terminal tail of the
protein, the most ﬂexible region in the C-domain is
loop 357–367 (Fig. S5). It is important to mention that
no noticeable differences in the values of R1, R2 and
15N{
1H}-NOE for the two protein conformers, mea-
sured at 298 K, were detected. This indicates that the
protein backbone mobility on the picosecond–nanosec-
Table 1. Statistics for the two ensembles of the calculated struc-
tures of the human C-domain (24 structures for the open
conformer and 24 for the closed conformer were analyzed).
Open Closed
Restraints used in the structure calculation
Total NOEs 1857 1852
Long range (|i–j| > 4) 497 490
Medium range (1 < |i–j| £ 4) 332 332
Sequential (|i–j| = 1) 516 516
Intraresidue 512 514
Residue dipolar couplings,
1DNH 90 69
Dihedral angles, total 216 214
Phi (u) 108 107
Psi (w) 108 107
Restraint violations and structural statistics (for 24 structures)
No NOE and dihedral angle violations over 0.2 A ˚ and 5 ,
respectively
Average rmsd over ensemble
From experimental restraints
Distance (A ˚) 0.017 ± 0.001 0.019 ± 0.004
Dihedral angles ( ) 0.42 ± 0.06 0.4 ± 0.1
From idealized geometry
Bonds (A ˚) 0.0022 ±
0.0001
0.0025 ±
0.0005
Bond angles ( ) 0.43 ± 0.01 0.49 ± 0.09
Improper angles ( ) 0.34 ± 0.01 0.40 ± 0.08
Percentage of residues in
the most favorable region
of the Ramachandran map
91.1 85.5
Percentage of residues in
disallowed region of the
Ramachandran map
00
Superimposition of the structures on the representative structure
rmsd over backbone C, CA, O
and N atoms of residues
277–328 and 373–413 (A ˚)
of the hydrophobic core
0.42 0.42
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15N-HSQC-NOESY spectrum measured at 298 K. The NOEs involving protons of residues from the open conformer
(A, C) and closed conformer (B, D) are shown.
Fig. 5. The relaxation parameters of the
amide
15N nuclei of each residue of the
C-domain, measured at 14 T (600 MHz
proton resonance frequency) and 298 K.
(A) The longitudinal relaxation rate, R1 (s
)1).
(B) The transverse relaxation rate, R2 (s
)1).
(C) The heteronuclear
15N,
1H-steady-state
NOE values. (D) The order parameter S
2,
determined by model-free analysis. (E)
Chemical exchange Rex contributions to the
transverse relaxation rates (s
)1).
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the closed conformers of the minidomain (Fig. S6).
A substantial contribution of chemical exchange,
Rex, to the transverse relaxation rate, R2, was observed
for residues 357–359 in the loop region (Fig. 5E). This
result is in good agreement with the observed confor-
mational changes between the open and the closed
conformers, as Phe357 exhibits the most signiﬁcant
structural perturbation. Structural changes for resi-
dues 358 and 359 are smaller, but still detectable.
Effect of mutations in the minidomain on stop
codon speciﬁcity
Superposition of the NMR structure of the human
C-domain on the full-length crystal structure of eRF1
reveals that the minidomain is located close to or adja-
cent to the N-domain (see Discussion), which is
responsible for the stop codon recognition (Fig. 6).
One can assume that complex dynamic behavior of the
minidomain may inﬂuence the state of the N-domain
and may therefore modify the efﬁciency of the decod-
ing process. To verify this hypothesis, we generated a
series of mutant forms of eRF1 with the replacement
of Tyr331, His334, His356, Phe357, Asp359, Gly363,
Glu365, His366 and Glu370 by alanine. These point
mutants were further assayed in a reconstituted in vitro
eukaryotic translation system containing 60S and 40S
ribosomal subunits, mRNA with different stop codons,
aminoacylated tRNAs, and individual puriﬁed transla-
tion factors [13]. The efﬁciency of termination was esti-
mated from the amount of released
35S-labeled peptide
at several time intervals. The mutations Y331A,
H356A, F357A, D359A, G363A and E365A in the
loop region were found to increase the termination
efﬁciency of the ribosomal complex with the UAG
stop codon, whereas the peptide release rate did not
change signiﬁcantly when UAA or UGA stop codons
were used (Fig. 7). The maximum impact on the pept-
idyl-tRNA hydrolysis was found for the E365A and
D359A mutants, in which negatively charged residues
were replaced by alanine. One can speculate that the
negative charges reduce the efﬁciency of the minido-
main interaction with mRNA. It is also worth noting
that the maximum impact was observed for mutations
in the ﬂexible loop 357–367. Replacement of His334,
His366 and Glu370 did not change the peptide release
rate, regardless of the stop codon used (Fig. S7).
In order to determine whether the observed effects
of the mutations could be caused by changes in the
efﬁciency of binding of eRF1 to eRF3, GTPase assays
were performed. As eRF3 coupling with eRF1 and the
ribosome results in activation of the eRF3 GTPase [4],
GTP hydrolysis in such a ternary complex could be
used to measure the efﬁciency of the eRF1–eRF3 inter-
action. All of the eRF1 mutants stimulated eRF3
GTPase activity nearly identically to that of the wild-
type protein (Table S2). These results indicate that the
C-domain is able to change the efﬁciency of stop
codon recognition in a context-dependent manner.
Discussion
Comparison with crystal structure of human
eRF1
The two reported crystal structures of human eRF1
(the protein itself, Protein Data Bank accession
code 1DT9; and the complex of eRF1 with eRF3, Pro-
tein Data Bank accession code 3E1Y] contain the
coordinates of the rigid protein core. However, these
structures do not show the coordinates of the atoms in
Fig. 6. Superposition of the representative NMR open conformer
of the C-domain (red and blue) on the crystal structure [20] of the
complex of human eRF1 (green) and the truncated eRF3 (purple).
The superposition was made using the Ca,C ¢ and N atoms of the
C-domain core residues. The minidomain is shown in red. The top
codon recognition NIKS sequence in the N-domain and the strictly
conserved GGQ triplet in the M-domain involved in peptidyl-tRNA
hydrolysis are indicated by spheres around Ca atoms. The minido-
main is close to the N-domain.
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this protein fragment. The NMR structure of the
human C-domain in solution reported here therefore
represents the ﬁrst view of this minidomain. Moreover,
it was found that this minidomain exists in two confor-
mations that undergo slow interconversion (on an
NMR time scale). The lifetime of these conformational
states is certainly longer than seconds, as no noticeable
convergence of the two sets of signals was detected,
even at 313 K.
Despite the rather simple topology of the minido-
main (three antiparallel b-strands and one a-helix on
top of the b-sheet), a search of the CATH database
(http://www.cathdb.info) [24] provided no direct struc-
tural homologs. The closest cluster of structures has
the fold found in the factor Xa inhibitor (CATH
code 4.10.410). An additional manual search based on
these results highlighted a structural homology
between the minidomain and the zinc-binding domain
of the zinc ﬁnger protein Ynr046w [25] (Fig. 8). The ﬁt
of the heavy atoms (Ca, C, and N) from three
b-strands and the a-helices of both the closed and the
open conformer onto a corresponding set of atoms of
Ynr046w gives rmsd values of 3.7 and 4.1 A ˚ , respec-
tively. Smaller rmsd values of 1.9 and 2.4 A ˚ are
obtained when the b-core residues only are used for
the superposition. Interestingly, this protein is a com-
ponent of yeast eRF1 methyltransferase, which is
involved in methylation of the Glu from the strictly
conserved GGQ tripeptide, and therefore it also, like
human eRF1, plays an important role in translation
termination.
The superposition of the families of solution struc-
tures of the two conformers onto the crystal structure of
human eRF1 (3E1Y) gives an rmsd for the heavy pro-
tein backbone atoms (N, Ca, and C¢) of 2.81 ± 0.13 A ˚
for all residues of the C-domain except for the highly
ﬂexible C-terminal tail (residues 414–437). A superposi-
tion made using the same set of atoms from only the res-
idues that belong to the main core of the protein gives a
smaller rmsd of 1.58 ± 0.06 A ˚ . Figure 6 shows a com-
parison of the structure of the protein core (resi-
dues 277–328 and 373–413) in solution and in the solid
state, and indicates their similarity.
A superposition of the C-domain NMR structure on
the crystal structure of the eRF1–eRF3 complex shows
that the minidomain is in close proximity to the
N-domain (Fig. 6). Recently, a molecular model of the
complex of human eRF1 with mRNA and tRNA has
been constructed [26]. Among the features of this com-
plex, the authors noted that the C-domain was close to
the mRNA stop codon region.
Stabilization of the two conformers
The two conformational states of the minidomain are
almost equally populated, indicating that the energies
Fig. 7. The rate of peptidyl-tRNA hydrolysis in response to human
eRF1 with mutations in the minidomain. The
35S-labeled tetrapep-
tide (MVHL) released as a function of time from termination com-
plexes formed with UAA (A), UAG (B) and UGA (C) stop codons by
wild-type eRF1 (solid circles) or mutant forms of eRF1 is shown.
The background release of tetrapeptide in the absence of eRF1
was subtracted from all graphs. The data are normalized to the
release given by wild-type eRF1 at 15 min.
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equal. The lifetime of each of the conformational
states, and therefore the energy barrier between them,
is relatively large. However, gel ﬁltration experiments
on the C-domain showed the presence of one peak
only (Fig. S8). Therefore, the two protein conformers
either have lifetimes of less than a few minutes or
have similar physical properties. One can speculate
that the two conformational states could be stabilized
by the network of coulombic interactions between the
charged side chains of the minidomain residues. The
minidomain is indeed enriched in polar and charged
residues, and the main structural difference between
the two conformers is in the relative position of the
side chain of His356 with respect to the negatively
charged Asp353 and Glu367. The carboxyl groups of
these two residues can form hydrogen bonds with the
HN proton of the His356 imidazole ring, either
directly or through a water molecule. His356 is near
Asp353 in the open conformer and near Glu365 and
Glu367 in the closed conformer, and these polar
interactions may play an important role in the stabil-
ization of the two conformers. The two His residues,
His334 and His356, may both participate in stabiliza-
tion of the polar interactions. Thus, His334, situated
on the central b-strand, could interact with the
Glu341 and Glu367. A stronger network of interac-
tions between Glu341, His334 (Glu367⁄Glu365) and
His356 in the closed conformer may partially explain
why the closed conformer is more rigid than the open
one.
The structure of loop 357–367 in both conformers
could also be stabilized by hydrogen bonds between
the backbone carbonyl oxygen of Asp359 and the
amide proton of Gly363 (Fig. S9). The distance
between these atoms in the open conformer family is
1.70 ± 0.02 A ˚ , and in the closed conformer it is
1.87 ± 0.10 A ˚ . Additionally, the conformation of this
loop could be partially stabilized by the interaction of
the carbonyl oxygen of Asp359 with the amide proton
of Thr362 (the distance in the open conformer family
is 2.34 ± 0.01 A ˚ , and in the closed conformer it is
2.56 ± 0.26 A ˚ ) and possibly by the hydrophobic inter-
actions of the methyl groups of Thr358 and Thr362
with a favorably oriented CH2 group of Asp359, inter-
actions that were conﬁrmed by the corresponding set
of NOEs.
Dynamic properties of the C-domain
The C-domain reveals a rather complex picture of
the mobility of its protein backbone. Analysis of the
15N-relaxation data shows that the protein core (resi-
dues 277–328 and 373–413) is rather rigid. This is in
full agreement with the results of the crystallographic
analysis of human eRF1 [19]. The minidomain,
which was not resolved in the crystal structures,
exists in two conformational states in solution. This
is evidence for the existence of protein backbone
conformational rearrangements occurring on a time
scale of seconds or slower. However, the amplitudes
of the motions of the minidomain backbone on the
picosecond–nanosecond time scale are rather small,
as shown by the large values of the order parameter
S
2, which are similar to the corresponding parame-
ters of residues in the protein core region. The most
ﬂexible parts of the minidomain are loops 335–339
and 357–367. An accurate analysis of
15N-relaxation
measurements of residues 335–339 was not possible,
owing to the overlapping of peaks in the
15N,
1H-cor-
relation spectra, but the dynamics of loop 357–367
were analyzed. As seen in Fig. 5D, the relative
amplitudes of the backbone motions of loop 357–367
were found to be larger than for all the other
protein domains except for the C-terminal tail (resi-
dues 414–437). Several residues from loop 357–367
also exhibited conformational rearrangements occur-
ring on the millisecond time scale (Fig. 5E). Overall,
Zn
A B C
Fig. 8. The topology of the zinc-binding
domain of zinc ﬁnger protein Ynr046w,
a component of the yeast eRF1 methyl-
transferase (A), and the minidomain
(residues 329–372) of human eRF1 in the
open (B) and closed (C) forms.
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the most characteristic feature of the dynamics of
the C-domain.
Possible functional role of the minidomain
There are several proteins that bind to eRF1. It has
been shown by deletion analysis that the catalytic sub-
unit of protein phosphatase 2A (PP2A) binds to
region 338–381 of eRF1 [27]. This region substantially
overlaps with the minidomain. It is not known whether
eRF1 is phosphorylated in vivo and whether the inter-
action of eRF1 with PP2A inﬂuences the termination
of translation [27]. The eRF1–PP2A interaction may
be important for another closely related process, non-
sense-mediated decay (NMD). Upf1p, a protein that
plays a key role in NMD [28,29], binds to an unknown
region of eRF1 [30]. Such an interaction halts transla-
tion termination and facilitates the degradation of
mRNA [30,31]. It should be noted that the ribonucleo-
protein complex, formed during NMD and containing
subunits of PP2A, plays a regulatory role in Upf1p
phosphorylation.
For termination of translation, eRF3 is one of the
most important interaction partners of eRF1. It has
been shown previously that both the M-domain [21]
and the C-domain [10,11,32] interact with eRF3.
Recently, it was also shown that the eRF1 interaction
interface with eRF3 is formed by two Arg residues,
Arg192 and Arg203, in the M-domain [21] and by a
cluster of hydrophobic residues, Phe291, Ile294,
Tyr301, Phe303, and Phe406, in the C-domain [20].
Residues 329–372 are situated on the opposite side of
the C-domain, and therefore do not participate
directly in the interaction with eRF3. This conclusion
was also conﬁrmed by the results of the GTPase
assays, which showed that mutations in the minido-
main of eRF1 did not change the GTPase activity of
eRF3.
The minidomain in the crystal structure is near the
N-terminal domain, which plays a key role in stop
codon recognition. The ability of the minidomain to
act as a conformational switch and its probable prox-
imity to the stop codon recognition site in the termi-
nation complex hint at its possible functional role.
The termination efﬁciencies of several eRF1 mutants
were examined. The residues for mutation were
selected from those that appeared to be important for
stabilization of the two protein conformers, i.e. those
in loop 357–367 and several neighboring residues. The
observed impact of the mutations at Tyr331, His356,
Phe357, Asp359, Gly363 and Glu365 on the termina-
tion efﬁciency of eRF1 with regard to UAG stop
codon recognition are in accord with the hypothesis
that the C-domain could be involved in the regulation
of translation termination. As Asp359 and Gly363 are
important for stabilization of both conformations of
loop 357–367, it is possible that stop codon speciﬁcity
is regulated by the conformation of this ﬂexible part
of the C-domain. His334, His366 and Glu370 are
located outside this loop, and this may explain the
absence of an effect of their replacement by Ala on
termination efﬁciency. Although the effects of the
mutations on peptide release are relatively modest, the
increase in efﬁciency (rather than a decrease) is never-
theless an important observation, and makes it more
likely that the phenomenon is caused by a direct inter-
action related to the UAG stop codon recognition
process.
It has also been reported that mutations in eRF3
that reduce its GTPase activity also decrease the efﬁ-
ciency of translation termination for some, but not
other, stop codons [14]. Thus, a 17-fold reduction in
termination efﬁciency was observed for the UGAC
stop signal, whereas much weaker effects were detected
in the case of other termination signals. The authors
suggested that the GTPase activity of eRF3 acts to
couple the recognition of translation termination sig-
nals by eRF1 to efﬁcient polypeptide chain release.
Genetic screening experiments also identiﬁed mutants
with changes in the C-terminal tail of yeast eRF1 that
were unable to recognize one of the three stop codons
[5]. Two of the mutations (Q415X and E428Q) are sit-
uated near the eRF3-binding motif, and could there-
fore inﬂuence the efﬁciency of the eRF1–eRF3
functional interaction [9,12]. The mutations in the
minidomain reported here have no impact on the
eRF1–eRF3 interaction, and are more likely to control
termination efﬁciency through a direct interaction with
the stop codon recognition sites.
It should be noted that loop 357–367 is one of the
most variable regions in the sequence of class 1
eukaryotic release factors [33] (Fig. S10). The majority
of eukaryotes utilize all three stop codons. However,
the frequencies of UAA, UAG and UGA in the coding
sequences of mRNAs differ between species [34]. It is
possible that the variable residue composition of
loop 357–367 may contribute to the modulation of the
afﬁnity of eRF1 for different stop codons according to
the most abundant termination signal in the transcrip-
tome. Indeed, UAG is a rare stop codon in the
Homo sapiens transcriptome [34], and is therefore a rel-
atively weak signal for human eRF1. Mutations in
loop 357–367 that increase the efﬁciency of eRF1 rec-
ognition of the UAG codon are in agreement with this
hypothesis.
A. B. Mantsyzov et al. NMR structure and function of the eRF1 C-domain
FEBS Journal 277 (2010) 2611–2627 ª 2010 The Authors Journal compilation ª 2010 FEBS 2621Experimental procedures
Sample preparation
The DNA fragment encoding the C-domain (residues 277–
437) with a C-terminal His6-tag fusion was cloned into the
pET23b(+) vector (Novagen) under the phage T7 RNA
polymerase promoter. The C-domain was overproduced in
Escherichia coli BL21(DE3), in M9 minimal medium, and
isolated using Ni
2+–nitrilotriacetic acid resin (Qiagen). The
protein was further puriﬁed by cation exchange chromatog-
raphy, using HiTrap SP columns (GE Healthcare). For
13C
and⁄or
15N labeling, [
13C6]d-glucose and⁄or
15NH4Cl
(Cambridge Isotope Laboratories) were used as the isotope
sources in M9 minimal medium. The samples for NMR
(protein concentration of  1m m) were prepared in either
95% H2O⁄5% D2O or 100% D2O and 10 mm potassium
phosphate and 50 mm KCl (pH 7.0). b-Mercaptoethanol
( 2m m) was added to the ﬁnal solution in order to pre-
vent oxidation of the free Cys residues Cys302 and Cys335.
Shigemi microcell NMR tubes, containing 330–380 lL,
were used in the recording of the NMR spectra.
Cloning and mutagenesis of human eRF1
Plasmids with mutant eRF1 genes were obtained by site-
directed mutagenesis, using the PCR-based ‘megaprimer’
method as described previously [6]. The resulting PCR
products were inserted into the XhoI–Bst98I sites of the
pERF4b plasmid. The sequences of the PCR primers used
for the generation of the eRF1 mutants are available upon
request.
Expression and puriﬁcation of human RFs
Wild-type human eRF1, its mutants and eRF3c containing
His6-tags at the C-termini were produced in
E. coli BL21(DE3), and puriﬁed as described previously
[6,13,35].
Puriﬁcation of initiation and elongation factors,
ribosomal subunits, and aminoacylation of tRNA
These are described elsewhere [12,36–39].
mRNA transcripts
mRNA was transcribed by T7 RNA polymerase on
MVHL-stop plasmids, encoding a T7 promoter, four CAA
repeats, the b-globin 5¢-UTR, the MVHL tetrapeptide fol-
lowed by one of three stop codons (UAA, UAG, or UGA)
and the 3¢-UTR, comprising the rest of the natural b-globin
coding sequence. The MVHL-stop plasmids (containing
UAA, UAG and UGA stop codons) were prepared as
described previously [39]. For run-off transcription, all plas-
mids were linearized with XhoI.
Pretermination complex assembly and
puriﬁcation
Pretermination complexes were assembled as described pre-
viously [12,39]. Brieﬂy, 37 pmol of MVHL-stop mRNA
was incubated in buffer A (20 mm Tris⁄acetate, pH 7.5,
100 mm potassium acetate, 2 mm dithiothreitol), supple-
mented with 400 u of RNase inhibitor (RiboLock, Fermen-
tas), 1 mm ATP, 0.25 mm spermidine, 0.2 mm GTP, 75 lg
of total tRNA (acylated with Val, Hist, Leu, and [
35S]Met),
75 pmol of 40S and 60S puriﬁed ribosomal subunits,
125 pmol each of eIF2, eIF3, eIF4F, eIF4A, eIF4B, eIF1,
eIF1A, eIF5, and eIF5B, 200 pmol of eEF1H and 50 pmol
of eEF2 for 30 min, and then centrifuged in a Beckman
SW55 rotor for 95 min at 4  C and 300 000 g (using a
Beckman SW55 rotor) on a 10–30% linear sucrose density
gradient prepared in buffer A with 5 mm MgCl2. Fractions
corresponding to pretermination complexes, according to
their optical density and the presence of [
35S]Met, were
combined, diluted three-fold with buffer A containing
1.25 mm MgCl2 (to a ﬁnal concentration of 2.5 mm Mg
2+),
and used for the peptide release assay.
Peptide release assays
These were performed as described previously [12], with
some minor modiﬁcations. Aliquots containing 0.1 pmol of
pretermination complexes, formed in the presence of
[
35S]Met-tRNA, and with an activity of about
10 000 c.p.m., were incubated at 37  C with 2.5 pmol of
eRF1 for 0–15 min. Ribosomes and tRNA were pelleted
with ice-cold 5% trichloroacetic acid, supplemented with
0.75% casamino acids, and centrifuged at 4  C and
14 000 g. The amount of released [
35S]Met-containing tetra-
peptide, which indicated the efﬁciency of peptidyl-tRNA
hydrolysis, was determined by scintillation counting of the
supernatants using an Intertechnique SL-30 liquid scintilla-
tion spectrometer.
GTPase activity assays
These were based on the measurement of the accumulation
of [
32P]Pi, using a modiﬁed charcoal precipitation method
[7]. The incubation mixture (12.5 lL) contained 20 mm
Tris⁄HCl (pH 7.5), 30 mm NH4Cl, 15 mm MgCl2, 0.16 lm
ribosomes, 0.16 lm human eRF3c, and 0.5 lm [
32P]GTP[cP]
(10 000 c.p.m.⁄pmol); human wild-type eRF1 or mutant
eRF1s were added to give 0.04, 0.08, 0.12 and 0.16 lm ﬁnal
concentrations. The reactions were run at 30  C for 20 min,
and terminated by mixing with 0.5 mL of a 5% activated
charcoal suspension in 50 mm NaH2PO4, cooled on ice. The
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at 4  C. Aliquots of the supernatants (0.375 mL) were
counted on a scintillation counter. Values of eRF3 GTPase
activity and corresponding error limits were estimated from
ﬁve experiments carried out for each eRF1 mutant.
Gel ﬁltration analysis of the C-domain
This was performed on Superose 12 in a buffer containing
20 mm Tris⁄HCl (pH 7.5), 100 mm KCl, 2 mm dithiothrei-
tol, and 5% glycerol. Only one peak was observed, indicat-
ing that the two conformational states could not be
separated by this method.
NMR spectroscopy
All spectra were acquired on Varian INOVA 600 and
800 MHz and Bruker AVANCE 600 and 700 MHz spec-
trometers equipped with triple-resonance z-gradient probes.
The 700 and 800 MHz spectrometers were equipped with
cryoprobes. Spectra were processed by nmrpipe, and ana-
lyzed using sparky (from Goddard and Kneller; http://
www.cgl.ucsf.edu/home/sparky) and autoassign [40].
Sequential backbone assignments [41] and side chains
assignments were obtained using 3D spectra obtained from
3D experiments correlating the amide NH with the C¢ signal
of the preceding amino acid, correlating the amide HN and
the Ca signals, correlating the amide HN and the Ca signal
of the preceding amino acid, correlating the amide NH with
the Ca and Cb signals, correlating the amide NH with the
Ca and Cb signals of the preceding amino acid, a three-
dimensional experiment correlating amide HN with Ha and
Hb signals (HNHAHB), three-dimensional experiment cor-
relating amide HN with Ha and Hb signals of preceding
residue via carbonyl carbon (HBHA(CO)NH) and three-
dimensional experiment correlating amide HN and Ha
signals (HNHA) [42], measured at 298 K, and three-dimen-
sional experiment correlating side-chain protons via
13C-
13C
correlations (HCCH)-TOCSY, measured at 313 K. Addi-
tional side chain assignments and NOE distance restraints
were extracted from the
1H,
13C-NOESY and
1H,
15N-NO-
ESY spectra measured at 298 and 313 K with 100 ms mix-
ing time. Assignments were obtained for more than 99% of
the
1H,
13C and
15N atoms of the protein backbone, and for
more than 78% of the side chain atoms.
The main set of backbone u and w dihedral angles was
calculated from the chemical shift values of backbone
atoms
13Ca,
13Cb,
13C¢,
1Ha,
1HN, and
15N, using talos
software [43]. Additional dihedral angles for those residues
with no agreement in talos were obtained by the angle-
search program [44].
RDC constants were measured using partially oriented
diluted liquid crystalline media:  5% (v⁄w) C12E5⁄hexa-
nol [23] and DHPC⁄DMPC bicelles [22]. In this series of
experiments, alternative orientations of the alignment ten-
sor were achieved by modifying the DHPC⁄DMPC bicelles
with SDS. Sixty-nine RDCs were measured in C12E5⁄hexa-
nol, and 90 in DHPC⁄DMPC⁄SDS, at 311 K. Neutral
5% (v⁄w) DHPC⁄DMPC bicelles were also used. However,
none of these measured RDCs was used in the subsequent
calculations, because of the very weak alignment of the pro-
tein in this medium (maximum dipolar interactions did not
exceed 5 Hz). The RDC values were calculated from the
1DJNH and
1JNH constants, extracted from the inphase anti-
phase (IPAP)-HSQC spectra [45], acquired in anisotropic
and isotropic conditions respectively.
Spectra for the measurement of
15N longitudinal relaxa-
tion rates (R1), transverse relaxation rates (R2) and
15N{
1H} heteronuclear NOE values were collected on a
 1m m
15N-labeled C-domain sample at 298 K with a
Varian INOVA 600 MHz NMR spectrometer, using pulse
sequences modiﬁed from those described by Kay et al. [46]
to compensate for cross-correlation effects [47].
Structure calculation and reﬁnement
The initial structure was generated in cns, using a set of
manually unambiguously assigned NOEs. The structure was
then submitted to aria, and further assigned NOEs were
obtained by an iterative procedure [48] using aria-cns [49].
NOE peak intensities were used for distance estimation,
instead of volumes, because of signiﬁcant crosspeak overlap-
ping. All of the measured proton–proton distances were
divided into ranges, with upper limits of 2.5, 3.0, 3.5, 4.0,
4.5, 5.0, 5.5 and 6.0 A ˚ . The structure calculations and reﬁne-
ment were performed by a simulated annealing protocol car-
ried out in Cartesian coordinate space using cns [50] and
the slightly modiﬁed script anneal.inp. The calculations
were performed in an iterative manner. Database values of
conformational torsion angle pseudopotentials [51] were
introduced at the ﬁnal stages of reﬁnement. The ﬁnal force
constants were as follows: NOE restraints, 75 kcalÆmol
)1ÆA ˚ 2;
dihedral angle restraints, 200 kcalÆmol
)1Ærad
2; RDCs,
50 kcalÆmol
)1ÆHz
2; and a scale factor for conformational
database restraints [10,51]. The weighting for the RDC
potential was scaled from 0.01 to 50. The restraint violations
were monitored after each cycle of reﬁnement by the in-
house program nmrest or the cns script accept.inp. Vio-
lated restraints were checked and corrected or declined. One
thousand eight hundred and ﬁfty-seven NOE-derived dis-
tance restraints, 216 dihedral angles and 90 RDCs were used
in the calculation of the ﬁnal ensemble (Table 1). The struc-
ture quality was analyzed with aqua and procheck-nmr
software [52] (Fig. S11) and by using the nmrest program.
The best 24 structures out of 100 (with respect to the mini-
mum restraints violation value criterion) were accepted as
the ﬁnal ensemble for each protein conformer.
Structure visualization and analysis were carried out
using the insightii software package (Accelrys Software
Inc.) and pymol (DeLano Scientiﬁc LLC).
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R1, R2 and
1H,
15N-heteronuclear NOE datasets of the
C-domain uniformly labeled with
15N were collected at
298 K on a 600 MHz Varian Inova spectrometer. The
delays for the R1 experiments were 0.6, 8.6, 24.7, 48.8, 96.9,
193.2, 345.7, 498.2, 795.2, 1196.4 and 1597.3 ms, and those
for the R2 experiments were 0, 8.6, 17.2, 25.8, 34.4, 43.0,
51.7, 60.3, 77.5 and 94.7 ms. The excitation time for
1Hi n
the
1H,
15N-heteronuclear NOE experiments was 4.0 s. Spec-
tra were processed using nmrpipe [53]. The nonlinear ﬁtting
of the integrated peak volumes in the pseudo-3D spectra of
the relaxation rate experiments and the calculation of stan-
dard deviations were accomplished using the nlinls proce-
dure. The values of R1 and R2 were then calculated from
the table of relative peak intensities, produced by nmrpipe
and nlinls, using relaxfit, which was written in-house
[54]. The standard deviations of the
15N{
1H}-NOE values
were calculated using the rmsd noise of the background
regions [55], and were further checked and corrected by
using two independently collected experimental datasets.
The analysis of the R1, R2 and
1H,
15N-NOE values was
carried out using a model-free formalism, with tensor 2.0
[56]. To determine the rotational diffusion tensor, all of the
isotropic, axially symmetric and fully asymmetric molecular
tumbling models were tested. Parameters of the tensors for
fully anisotropic diffusion of the open and closed conform-
ers are presented in Table 2. The values of the diffusion
tensor axis were then used to ﬁt models of internal motions
for the backbone HN vectors of the amino acids. Five
models were tested during the calculation: (a) a rigid body
model (using the very fast internal motions, tc < 20 ps)
(model 1); (b) the model-free Lipari–Szabo model [57]
(model 2); (c) the Lipari–Szabo model with the inclusion of
the chemical exchange contribution, Rex, to the transverse
relaxation rates [58] (model 3); (d) a rigid body model with
the inclusion of the chemical exchange contribution
(model 4); and (e) the model-free Lipari–Szabo model with
an extension to include slower internal motions occurring
on a nanosecond time scale [59] (model 5).
Typically, most of the residues of the protein rigid core
could be successfully ﬁtted using models 1 and 2. For a few
residues of the minidomain (330–332, at the beginning of
the central b-strand) and residues 343 and 351, model 1
was selected as the best. For residues 357–359 of the mini-
domain and for several other residues, a signiﬁcant contri-
bution of chemical exchange was observed, and model 3
had to be used to ﬁt the relaxation data. For the other resi-
dues of the minidomain, model 2 was selected. Model 5
was applied only to ﬁt the relaxation data obtained for the
residues from the ﬂexible C-terminal tail.
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Fig. S4. Representative NOEs in the open and closed
conformers of the minidomain of human eRF1.
Fig. S5. A cylindrical ribbon representation of the
backbone of the C-terminal domain of human eRF1.
Fig. S6. The order parameter, S
2, calculated separately
for the open and closed conformers of the C-terminal
domain of human eRF1 using a model-free analysis
with an assumption of fully asymmetric molecular
motions and tensors.
Fig. S7. The rate of peptidyl-tRNA hydrolysis in
response to human eRF1, with mutations in the mini-
domain (H334A, H366A, and E370A).
Fig. S8. Results of the gel ﬁltration and SDS⁄PAGE
(8% acrylamide) of the C-terminal domain of human
eRF1.
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363) by a network of hydrogen bonds.
Fig. S10. Multiple sequence alignment of eRF1.
Fig. S11. The Ramachandran map plot (/ and w tor-
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the closed and open conformers of the C-terminal
domain of human eRF1.
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